Pimavanserin Clinical Trials for Parkinson's
Pimavanserin is being studied in recruiting Parkinson's disease clinical trials. This page lists the recruiting trials we currently track that involve Pimavanserin, sourced daily from ClinicalTrials.gov and translated into plain language for families.
Below are the recruiting trials that name Pimavanserin. Sign up to be emailed the moment a new Pimavanserin trial opens.
3 Recruiting Pimavanserin Trials
- Reduce depressive symptoms in Parkinsons, NCT06455293, PHASE2, RECRUITING
- Compare pimavanserin and quetiapine effectiveness, NCT05590637, PHASE4, RECRUITING
- Reduce hallucinations without worsening movement, NCT04373317, PHASE4, RECRUITING